NCT01216384View on ClinicalTrials.gov

Single Rising Dose (SRD), Multiple Rising Dose (MRD) Study of BI 671800 in Healthy Asian Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

73

Participants

Timeline

Start Date

October 31, 2010

Primary Completion Date

December 31, 2010

Conditions
AsthmaRhinitis, Allergic, Perennial
Interventions
DRUG

BI 671800

In the SRD part subjects will receive a single dose and in the MRD part subjects will receive a total of 14 doses.

DRUG

placebo

Subjects will receive according to the dose group matching number of placebo tablets

Trial Locations (1)

Unknown

1268.15.8201 Boehringer Ingelheim Investigational Site, Seoul

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY